Facebook link Linked In link You Tube link

FOCIS 2013 Header

About Program at a Glance Abstracts Visit Seaport Support/Exhibit

 Important Dates & Deadlines
Abstract submissions open  Monday, December 3, 2012
Abstract submission deadline extended to February 1, 11:59 pm EST  Friday, February 1, 2013
All abstract presenters must be registered for FOCIS 2013 (or abstract may be withdrawn)  Wednesday, April 3, 2013
Late-breaking abstract submission deadline  Monday, April 8, 2013
FOCIS 2013  June 27 - June 30, 2013

View the 2013 Abstract Supplement

Abstract Fee
There is a $30 non-refundable submission fee per abstract for FOCIS non-member presenting authors. This fee is waived for presenting authors who are FOCIS members.
 Join FOCIS prior to abstract submission to ensure that your fee is waived. If you submit your abstract prior to joining FOCIS, your abstract fee will not be refunded. Please note: Only the presenting author should submit abstracts.

Abstract Placement
The FOCIS Scientific Program Committee has sole discretion regarding placement of abstracts within the FOCIS program. Abstracts are considered for either an oral or poster presentation. Please indicate your preference for oral or poster presentation format during online submission.

Abstract Presentation
Presenting authors must submit the abstract and must be prepared to present the abstract at FOCIS 2013 should it be accepted. Posters will not be allowed without an accompanying presenter.

• Posters should fit on a poster board that is 4 feet wide (horizontal) by 4 feet high (vertical).
• Posters MUST be removed from the poster area immediately following your session.
• Posters remaining in the hall after the poster session will be disposed of.

Abstract Publication
Abstracts accepted for presentation and properly registered by April 3, will be published in PDF format on the FOCIS website.

Changes and Withdrawals
Please review your submission carefully. No revisions, including author information and/or new data, will be accepted after the deadline. Withdrawals of abstracts must be received in writing before April 3, 2013. 

Deadline
The deadline for submitting abstracts is February 1, 2013, 11:59 pm Eastern Time. 

Disclosure
All presenting authors MUST submit a completed disclosure form. This policy has been established in cooperation with ACCME guidelines.

Eligibility
FOCIS members, members of any of the FOCIS Member Societies or FOCIS Centers of Excellence, as well as non-members are eligible to submit abstracts.

Graphics/Charts
Graphic elements, such as charts, pictures, etc., may NOT be included in abstract submission and will not be considered.

Notification
Acceptance and rejections notifications will be sent the week of March 18th. Late breaking abstract presenting authors will be notified the week of April 2. If your abstract’s contact author does not receive notification of your abstract's status, please contact the FOCIS Executive Office at (414) 359-1670 or This email address is being protected from spambots. You need JavaScript enabled to view it. .

Registration Policy
Abstract submitters who are accepted for a poster presentation at FOCIS 2013 MUST register to attend the meeting by April 3, 2013, for their abstract to be included in the FOCIS 2013 Abstract Supplement and their posters to be scheduled in a poster session. Submitters who are accepted, but do not register will be considered withdrawals, and will not be included in the Scientific Program or online Abstract Supplement.

Review Process
Each abstract is blinded and peer-reviewed by three members of the Abstract Review Committee.

Travel Awards
Travel awards are available to select abstract presenters chosen for presentation at FOCIS 2013. All abstracts are considered for travel awards. The number and amount of the awards is based upon several factors including geographic location, placement of abstract within the FOCIS program and funds available. In 2012, FOCIS awarded more than 50 travel awards.   

Sample Abstract

(1) Foxp3 (Scurfy) Mutation Greatly Accelerates Diabetes in Insulin-specific TCR Transgenic Mice 

(2) Jean Jasinski1, Maki Nakayama1, Kelly Johnson1, Liping Yu1, George Eisenbarth1, University of Colorado Health Sciences Center, Barbara Davis Center, Aurora, CO 

(3) Previously we developed and described the development of a transgenic mouse expressing an insulin-specific (ins2 B:9–23) T cell receptor mouse model (BDC12-4.1). This pathogenic model exhibited spontaneous diabetes development on a backcross-1 (FVB×NOD)×NOD background. (Abstract is continued; this is a sample only.)

(1) = Title: Mixed case, no punctuation at end. 

(2) = Author Information: In proper author order with all institutional information included.

(3) = Abstract Body: 250 word count, not including abstract title or author information.

**Charts or graphics of any kind may NOT be included in abstract submission. **

Questions? Please contact the Executive Office by This email address is being protected from spambots. You need JavaScript enabled to view it. or by calling 1-414-359-1670.

Share